Daré Bioscience (DARE) Institutional Ownership $3.21 +0.03 (+0.94%) (As of 01:21 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Daré Bioscience (NASDAQ:DARE)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$63.72KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$3.81M Get DARE Insider Trade Alerts Want to know when executives and insiders are buying or selling Daré Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DARE Institutional Buying and Selling by Quarter Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Daré Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC89,060$289K0.0%-91.2%1.042% 11/15/2024 State Street Corp23,515$76K0.0%-91.7%0.275% 8/9/2024 Renaissance Technologies LLC778,700$262K0.0%+2.1%9.247% 11/15/2023 Armistice Capital LLC6,470,000$2.99M0.0%N/A7.370% 5/1/2023Virtu Financial LLC32,481$34K0.0%-58.1%0.038% 2/8/2023 Founders Financial Securities LLC114,000$95K0.0%-67.2%0.134% Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. 11/7/2022Virtu Financial LLC68,242$68K0.0%+29.2%0.080% 10/27/2022 Founders Financial Securities LLC347,824$5.27M0.9%+236.1%0.410% 7/27/2022 Founders Financial Securities LLC103,500$127K0.0%N/A0.122% 7/19/2022Commonwealth Equity Services LLC43,579$53K0.0%+57.8%0.051% 5/11/2022 GSA Capital Partners LLP125,954$188K0.0%-11.2%0.150% 5/10/2022 Buckingham Strategic Partners30,000$45K0.0%+200.0%0.036% 2/14/2022 GSA Capital Partners LLP141,843$284K0.0%+1,077.5%0.185% 2/8/2022Raymond James Financial Services Advisors Inc.30,000$60K0.0%N/A0.039% 11/15/2021 HighTower Advisors LLC22,035$36K0.0%-26.6%0.031% 11/12/2021 Renaissance Technologies LLC324,030$541K0.0%+346.4%0.459% 11/10/2021 Goldman Sachs Group Inc.255,282$426K0.0%+1,349.9%0.362% 11/9/2021BlackRock Inc.122,725$205K0.0%-9.0%0.174% 10/19/2021Interwest Venture Management Co.62,065$104K0.0%+23.2%0.088% 10/15/2021 Paradigm Strategies in Wealth Management LLC23,105$39K0.0%+131.1%0.033% 8/16/2021 State Street Corp62,630$118K0.0%N/A0.127% 8/13/2021 Renaissance Technologies LLC72,590$137K0.0%-91.7%0.147% 8/13/2021 Geode Capital Management LLC310,318$586K0.0%+19.7%0.629% 8/13/2021 Vanguard Group Inc.1,941,258$3.67M0.0%+37.2%3.934% 8/12/2021 XTX Topco Ltd14,101$27K0.0%N/A0.029% 8/11/2021Commonwealth Equity Services LLC25,875$48K0.0%+55.6%0.052% 8/6/2021 HighTower Advisors LLC30,035$57K0.0%+87.3%0.061% 5/19/2021Virtu Financial LLC149,593$253K0.0%+549.5%0.303% 5/19/2021 Squarepoint Ops LLC142,133$240K0.0%N/A0.288% 5/17/2021 Goldman Sachs Group Inc.24,555$41K0.0%-78.8%0.052% 5/13/2021 Renaissance Technologies LLC872,408$1.47M0.0%+23.3%1.844% 5/12/2021 Geode Capital Management LLC259,243$438K0.0%+22.8%0.548% 5/12/2021 CIBC Private Wealth Group LLC25,000$42K0.0%N/A0.053% 5/10/2021 HighTower Advisors LLC16,035$27K0.0%-49.9%0.034% 5/4/2021Commonwealth Equity Services LLC16,625$28K0.0%N/A0.035% 2/10/2021 HighTower Advisors LLC32,034$42K0.0%+33.3%0.077% 2/4/2021 GSA Capital Partners LLP144,323$193K0.0%N/A0.347% (Data available from 1/1/2016 forward) DARE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DARE shares? During the previous two years, the following institutional investors and hedge funds held shares of Daré Bioscience shares: Armistice Capital LLC ($2.99M), Geode Capital Management LLC ($289K), Renaissance Technologies LLC ($262K), Founders Financial Securities LLC ($95K), and State Street Corp ($76K), Virtu Financial LLC ($34K).Learn more on DARE's institutional investors. What percentage of Daré Bioscience stock is owned by institutional investors? 6.70% of Daré Bioscience stock is owned by institutional investors. Learn more on DARE's institutional investor holdings. Which institutional investors have been buying Daré Bioscience stock? The following institutional investors have purchased Daré Bioscience stock in the last 24 months: Armistice Capital LLC ($6.47M), and Renaissance Technologies LLC ($15.80K). How much institutional buying is happening at Daré Bioscience? Institutional investors have bought a total of 6,485,800 shares in the last 24 months. This purchase volume represents approximately $35.92M in transactions. Which Daré Bioscience major shareholders have been selling company stock? The following institutional investors have sold Daré Bioscience stock in the last 24 months: Geode Capital Management LLC ($917.50K), State Street Corp ($258.70K), Founders Financial Securities LLC ($233.82K), and Virtu Financial LLC ($44.99K). How much institutional selling is happening at Daré Bioscience? Institutional investors have sold a total of 1,455,008 shares in the last 24 months. This volume of shares sold represents approximately $6.70M in transactions. Related Companies Vistagen Therapeutics Major Shareholders Avalo Therapeutics Major Shareholders Rani Therapeutics Major Shareholders Alto Neuroscience Major Shareholders Scilex Major Shareholders Vaxart Major Shareholders Journey Medical Major Shareholders INmune Bio Major Shareholders Cellectis Major Shareholders Century Therapeutics Major Shareholders This page (NASDAQ:DARE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daré Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DARE Stock Alerts